A recent study showed that cetuximab treatment was effective in wild type K-ras and EGFR Chinese CRC patients, which provided evidence for efficacy-prediction of EGFR targeting therapeutic strategies [22,23]. Here, KRAS is linked to colorectal carcinoma.